SEC Filings

Filing date	Form	Description	View
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002993.pdf 0001179110-17-002993.rtf 0001179110-17-002993.xls
02/14/17	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-17-002106.pdf 0000315066-17-002106.rtf
02/14/17	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001140361-17-007331.pdf 0001140361-17-007331.rtf 0001140361-17-007331.xls
02/14/17	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-17-001380.pdf 0001213900-17-001380.rtf 0001213900-17-001380.xls
02/14/17	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-17-001381.pdf 0001213900-17-001381.rtf 0001213900-17-001381.xls
02/10/17	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000932471-17-001931.pdf 0000932471-17-001931.rtf
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-001999.pdf 0001179110-17-001999.rtf 0001179110-17-001999.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-001998.pdf 0001179110-17-001998.rtf 0001179110-17-001998.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-001997.pdf 0001179110-17-001997.rtf 0001179110-17-001997.xls
02/08/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002001.pdf 0001179110-17-002001.rtf 0001179110-17-002001.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools